Literature DB >> 32203287

Top companies and drugs by sales in 2019.

Lisa Urquhart.   

Abstract

Year:  2020        PMID： 32203287     DOI： 10.1038/d41573-020-00047-7

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  18 in total

Review 1.  Strategies for delivering therapeutics across the blood-brain barrier.

Authors:  Georg C Terstappen; Axel H Meyer; Robert D Bell; Wandong Zhang
Journal:  Nat Rev Drug Discov       Date:  2021-03-01       Impact factor: 84.694

2.  Engineered antibodies to combat viral threats.

Authors:  Xiaojie Yu; Mark S Cragg
Journal:  Nature       Date:  2020-12       Impact factor: 49.962

Review 3.  Factors Affecting the Expression of Recombinant Protein and Improvement Strategies in Chinese Hamster Ovary Cells.

Authors:  Zheng-Mei Li; Zhen-Lin Fan; Xiao-Yin Wang; Tian-Yun Wang
Journal:  Front Bioeng Biotechnol       Date:  2022-07-04

4.  A Hybrid Adherent/Suspension Cell-Based Selection Strategy for Discovery of Antibodies Targeting Membrane Proteins.

Authors:  Patrick J Krohl; Jamie B Spangler
Journal:  Methods Mol Biol       Date:  2022

Review 5.  Overview of Humira® Biosimilars: Current European Landscape and Future Implications.

Authors:  Jill Coghlan; Hongliang He; Anna S Schwendeman
Journal:  J Pharm Sci       Date:  2021-02-05       Impact factor: 3.534

6.  The First WHO International Standard for Adalimumab: Dual Role in Bioactivity and Therapeutic Drug Monitoring.

Authors:  Meenu Wadhwa; Chris Bird; Eleanor Atkinson; Isabelle Cludts; Peter Rigsby
Journal:  Front Immunol       Date:  2021-04-15       Impact factor: 7.561

7.  A "ligand-targeting" peptide-drug conjugate: Targeted intracellular drug delivery by VEGF-binding helix-loop-helix peptides via receptor-mediated endocytosis.

Authors:  Masataka Michigami; Kentaro Takahashi; Haruna Yamashita; Zhengmao Ye; Ikuhiko Nakase; Ikuo Fujii
Journal:  PLoS One       Date:  2021-02-25       Impact factor: 3.240

Review 8.  Harnessing the potential of machine learning for advancing "Quality by Design" in biomanufacturing.

Authors:  Ian Walsh; Matthew Myint; Terry Nguyen-Khuong; Ying Swan Ho; Say Kong Ng; Meiyappan Lakshmanan
Journal:  MAbs       Date:  2022 Jan-Dec       Impact factor: 5.857

9.  Shooting yourself in the foot: How immune cells induce antibiotic tolerance in microbial pathogens.

Authors:  Jenna E Beam; Sarah E Rowe; Brian P Conlon
Journal:  PLoS Pathog       Date:  2021-07-22       Impact factor: 6.823

Review 10.  Phage Display Derived Monoclonal Antibodies: From Bench to Bedside.

Authors:  Mohamed A Alfaleh; Hashem O Alsaab; Ahmad Bakur Mahmoud; Almohanad A Alkayyal; Martina L Jones; Stephen M Mahler; Anwar M Hashem
Journal:  Front Immunol       Date:  2020-08-28       Impact factor: 7.561
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.